Ladiratuzumab vedotin (ADC)
Ladiratuzumab vedotin is an ADC consisting of a LIV-1-directed antibody and Monomethyl auristatin E (MMAE) used for the study of breast cancer.
Product Specifications
Product Name Alternative
SGN-LIV1A
Reactivity
Human
Applications
Research Grade Biosimilar
Stability
Use a manual defrost freezer and avoid repeated freeze-thaw cycles. Store at 4°C short term (1-2 weeks) . Store at -20°C 12 months. Store at -80°C long term.
Endotoxin
Please contact with the lab for this information.
Purity
>90% as determined by SEC.
Form
Liquid
Notes
For research use only. Not suitable for clinical or therapeutic use.
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MBS7083406 Inquire
Recombinant Staphylococcus aureus PTS system glucose-specific EIICBA component (ptsG), partial
Ask
View Details 